Oxford vax behind fewer Covid deaths in Britain, claims expert

London, December 27

Britain’s early deployment of the Oxford/AstraZeneca vaccine to protect against Covid may be responsible for the country’s lower death rates compared to other European countries, a UK vaccine expert has said.

Dr Clive Dix, former chairman of the UK’s Vaccine Task Force, told the Daily Telegraph that the Oxford/AstraZeneca vaccine – manufactured and administered in India as Covishield – may offer stronger long-term protection against severe Covid and death.

“If you look across Europe, with the rise in cases, there’s also a corresponding lagged rise in deaths, but not in the UK, and we have to understand that,” said Dr Dix. “I personally believe that’s because most of our vulnerable people were given the AstraZeneca vaccine,” he said.

According to Our World in Data, a website run by the University of Oxford, the UK has 1.7 daily deaths from Covid per million people. In comparison, the EU as a whole has almost four.

The key, Dix believes, is that although the RNA jabs such as Pfizer/BioNTech produce a more obvious and rapid jump in antibody levels in lab tests, other vaccines may be better at priming another part of the immune system called cellular immunity. — PTI 

Oz reports 1st Omicron death

Sydney: New South Wales, Australia’s most populous state, confirmed its first death from the Omicron variant and reported more than 6,000 new Covid cases on Monday. The fatal case was identified as a man in his 80s who was infected at an aged care facility in western Sydney. He was fully vaccinated, but had underlying health conditions. AP

1.7 daily deaths per 1 million

According to Our World in Data, a website run by the University of Oxford, the UK has 1.7 daily deaths from Covid per million people. In comparison, the European Union (EU) as a whole has almost four.

Israel begins 4th dose trial

Jerusalem: Israel has begun trials of a fourth dose of Covid vaccine in what is believed to be the first study of its kind. The trial began at Sheba Medical Centre, outside Tel Aviv, with 150 medical personnel who received a booster dose in August receiving a fourth shot of Pfizer vaccine. The staff were tested and found to have low antibody levels. AP